Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Diazepam Binding Inhibitor (DBI) (N-Term) Peptid

DBI Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN975604
  • Target Alle Diazepam Binding Inhibitor (DBI) Produkte
    Diazepam Binding Inhibitor (DBI)
    Protein Region
    N-Term
    Spezies
    Human
    Quelle
    • 5
    Synthetic
    Applikation
    Blocking Peptide (BP), Western Blotting (WB)
    Sequenz
    MWGDLWLLPP ASANPGTGTE AEFEKAAEEV RHLKTKPSDE EMLFIYGHYK
    Produktmerkmale
    This is a synthetic peptide designed for use in combination with anti-DBI Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Aufreinigung
    Purified
  • Applikationshinweise
    Each Investigator should determine their own optimal working dilution for specific applications.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Konzentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Handhabung
    Avoid repeated freeze-thaw cycles.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    Diazepam Binding Inhibitor (DBI)
    Synonyme
    ACBD1 Peptide, ACBP Peptide, CCK-RP Peptide, EP Peptide, dbib Peptide, DBI Peptide, wu:fb63e10 Peptide, zgc:56108 Peptide, zgc:77734 Peptide, Acbp Peptide, endozepine Peptide, Acoabp3 Peptide, Ep Peptide, Odn Peptide, RNACOABP3 Peptide, Ttn Peptide, acbd1 Peptide, acbp Peptide, cck-rp Peptide, dbi Peptide, dbi-a Peptide, dbi-b Peptide, dbia Peptide, diazepam binding inhibitor, acyl-CoA binding protein Peptide, diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) S homeolog Peptide, diazepam-binding inhibitor Peptide, diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) Peptide, acyl-CoA-binding protein Peptide, diazepam binding inhibitor Peptide, diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) L homeolog Peptide, DBI Peptide, dbi.S Peptide, dbi Peptide, LOC706367 Peptide, Dbi Peptide, dbi.L Peptide
    Hintergrund
    DBI is diazepam binding inhibitor. The protein that is regulated by hormones and is involved in lipid metabolism and the displacement of beta-carbolines and benzodiazepines, which modulate signal transduction at type A gamma-aminobutyric acid receptors located in brain synapses. DBI is conserved from yeast to mammals, with the most highly conserved domain consisting of seven contiguous residues that constitute the hydrophobic binding site for medium- and long-chain acyl-Coenzyme A esters. Diazepam binding inhibitor is also known to mediate the feedback regulation of pancreatic secretion and the postprandial release of cholecystokinin, in addition to its role as a mediator in corticotropin-dependent adrenal steroidogenesis. Three pseudogenes located on chromosomes 6, 8 and 16 have been identified. Multiple transcript variants encoding different isoforms have been described for this gene.

    Alias Symbols: ACBD1, ACBP, CCK-RP, EP, MGC70414

    Protein Interaction Partner: PPCDC,TSPO

    Protein Size: 104
    Molekulargewicht
    12 kDa
    Gen-ID
    1622
    NCBI Accession
    NM_020548, NP_065438
    UniProt
    B8ZWD2
Sie sind hier:
Kundenservice